Retraction Note: Inhibition effects of acridone on the growth of breast cancer cells in vivo

Eur Rev Med Pharmacol Sci. 2024 May;28(9):3292. doi: 10.26355/eurrev_202405_36201.

Abstract

The article "Inhibition effects of acridone on the growth of breast cancer cells in vivo", by Y.-F. Xia, H.-J. Chu, G.-F. Kuang, G.-J. Jiang, Y.-C. Che, published in Eur Rev Med Pharmacol Sci 2018; 22 (8): 2356-2363-DOI: 10.26355/eurrev_201804_14827-PMID: 29762857 has been retracted by the Editor in Chief for the following reasons. Following some concerns raised on PubPeer regarding a possible overlap in Figure 2, the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal investigation revealed a duplication between Figures 2B and 2C. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. The authors have been informed about the journal's investigation but remained unresponsive. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/14827.

Publication types

  • Retraction of Publication

MeSH terms

  • Acridones* / pharmacology
  • Animals
  • Antineoplastic Agents / pharmacology
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / pathology
  • Cell Line, Tumor
  • Cell Proliferation* / drug effects
  • Female
  • Humans
  • Mice

Substances

  • acridone